1. Home
  2. CERS vs TRVG Comparison

CERS vs TRVG Comparison

Compare CERS & TRVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERS
  • TRVG
  • Stock Information
  • Founded
  • CERS 1991
  • TRVG 2005
  • Country
  • CERS United States
  • TRVG Germany
  • Employees
  • CERS N/A
  • TRVG N/A
  • Industry
  • CERS EDP Services
  • TRVG EDP Services
  • Sector
  • CERS Technology
  • TRVG Technology
  • Exchange
  • CERS Nasdaq
  • TRVG Nasdaq
  • Market Cap
  • CERS 347.3M
  • TRVG 306.5M
  • IPO Year
  • CERS 1997
  • TRVG N/A
  • Fundamental
  • Price
  • CERS $1.27
  • TRVG $4.03
  • Analyst Decision
  • CERS Strong Buy
  • TRVG Buy
  • Analyst Count
  • CERS 2
  • TRVG 4
  • Target Price
  • CERS $3.50
  • TRVG $4.88
  • AVG Volume (30 Days)
  • CERS 1.2M
  • TRVG 138.1K
  • Earning Date
  • CERS 05-01-2025
  • TRVG 07-29-2025
  • Dividend Yield
  • CERS N/A
  • TRVG N/A
  • EPS Growth
  • CERS N/A
  • TRVG N/A
  • EPS
  • CERS N/A
  • TRVG N/A
  • Revenue
  • CERS $185,144,000.00
  • TRVG $522,618,892.00
  • Revenue This Year
  • CERS $22.37
  • TRVG $13.01
  • Revenue Next Year
  • CERS $8.46
  • TRVG $7.04
  • P/E Ratio
  • CERS N/A
  • TRVG N/A
  • Revenue Growth
  • CERS 13.06
  • TRVG 1.70
  • 52 Week Low
  • CERS $1.12
  • TRVG $1.60
  • 52 Week High
  • CERS $2.54
  • TRVG $5.83
  • Technical
  • Relative Strength Index (RSI)
  • CERS 46.48
  • TRVG 41.63
  • Support Level
  • CERS $1.21
  • TRVG $4.05
  • Resistance Level
  • CERS $1.35
  • TRVG $4.65
  • Average True Range (ATR)
  • CERS 0.06
  • TRVG 0.28
  • MACD
  • CERS -0.00
  • TRVG -0.09
  • Stochastic Oscillator
  • CERS 38.89
  • TRVG 3.05

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. It derives a majority of revenue from the Developed Europe segment. The Developed Europe segment is comprised of Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Malta, the Netherlands, Norway, Portugal, Spain, Sweden, and others.

Share on Social Networks: